Premium
Monoclonal and polyclonal humoral immune response to EC HER‐2/ NEU peptides with low similarity to the host's proteome
Author(s) -
Mittelman Abraham,
Lucchese Alberta,
Sinha Animesh A.,
Kanduc Darja
Publication year - 2002
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.10259
Subject(s) - proteome , polyclonal antibodies , biology , epitope , monoclonal antibody , immunogenicity , antigen , immune system , microbiology and biotechnology , immunology , antibody , biochemistry
We are studying peptide immunogenicity as a function of the similarity level to the host's proteome. By using as a model the breast/prostate cancer‐associated HER‐2/ neu antigen, we analyzed the monoclonal and polyclonal humoral immune responses against HER‐2/ neu peptide motifs not shared with the host proteome. We show here that (i) a mouse monoclonal antibody (MAb) raised against the extracellular domain (EC) of human HER‐2/neu oncoprotein recognized a linear peptide motif endowed with low similarity level to the mouse proteome; (ii) likewise, human sera from breast/prostate cancer patients preferentially recognized peptide fragments from the EC of the HER‐2/ neu oncoprotein having sequences that are not present in the human proteome. Together with previous results obtained in other disease models (cervical cancer‐associated HPV16 E7 oncoprotein and Pemphigus vulgaris auto‐antigen desmoglein‐3), the present data suggest that a low level of sequence similarity to the host's proteome might be an important factor in shaping the pool of B cell epitopes. © 2002 Wiley‐Liss, Inc.